Global Veterinary Biologics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Veterinary Biologics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Veterinary biologics are vaccines, antigens, antitoxins and other preparations made from living organisms (or genetically engineered) and intended for use in diagnosing, treating, or immunizing animals. Unlike some pharmaceutical products, such as antibiotics, most biologics leave no residues in animals.
Veterinary Biologics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Veterinary Biologics market is projected to reach US$ 17220 million in 2029, increasing from US$ 10810 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2029. Demand from Llivestock and Equine are the major drivers for the industry.
The Animal Healthcare market is primarily driven by the increasing awareness about animal health and well-being, coupled with the rising prevalence of various animal diseases. Pet ownership has grown, leading to higher demand for veterinary services and products. Additionally, the growth of the livestock industry to meet global food demand further boosts the need for animal healthcare products. Advances in veterinary medicine and technology are also driving market growth, enabling better diagnosis, treatment, and preventive care for animals. However, challenges include regulatory complexities and the high cost of certain treatments, which can hinder accessibility for some pet owners or farmers. Striking a balance between quality care and affordability is crucial for the sustainable growth of the animal healthcare market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Veterinary Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco/Eli Lilly
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken
FATRO
Vaksindo
Bio-Labs
Avimex Animal
Segment by Type
Vaccines
Monoclonal Antibodies
Llivestock
Equine
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Veterinary Biologics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Veterinary Biologics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Veterinary Biologics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Veterinary Biologics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Veterinary Biologics introduction, etc. Veterinary Biologics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Veterinary Biologics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Veterinary Biologics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Veterinary Biologics market is projected to reach US$ 17220 million in 2029, increasing from US$ 10810 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2029. Demand from Llivestock and Equine are the major drivers for the industry.
The Animal Healthcare market is primarily driven by the increasing awareness about animal health and well-being, coupled with the rising prevalence of various animal diseases. Pet ownership has grown, leading to higher demand for veterinary services and products. Additionally, the growth of the livestock industry to meet global food demand further boosts the need for animal healthcare products. Advances in veterinary medicine and technology are also driving market growth, enabling better diagnosis, treatment, and preventive care for animals. However, challenges include regulatory complexities and the high cost of certain treatments, which can hinder accessibility for some pet owners or farmers. Striking a balance between quality care and affordability is crucial for the sustainable growth of the animal healthcare market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Veterinary Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco/Eli Lilly
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken
FATRO
Vaksindo
Bio-Labs
Avimex Animal
Segment by Type
Vaccines
Monoclonal Antibodies
Segment by Application
Llivestock
Equine
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Veterinary Biologics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Veterinary Biologics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Veterinary Biologics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Veterinary Biologics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Veterinary Biologics introduction, etc. Veterinary Biologics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Veterinary Biologics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
